Poster Presentations / Axolabs

Selected Poster Presentations

Oligonucleotide synthesis

Investigating the Impact of Linear Flow Rate on Purification Performance (2024)
Reaction condition optimization to minimize hydrolysate formation in a maleimide-NHS esteroligonucleotide conjugation reaction (2024)
Synthesis, uptake and biological activity of multimers of C-miR146a: a conjugate of CpG-rich deoxynucleotide D19 and micro-RNA miR146a (2021)
An alternative desilylation condition using NH4F (2023)
Efficient cadmium removal via EDTA chelation (2023) (see Video)
Scale-Up capsule filtration of oligonucleotide solutions for cGMP use (2022)
Optimization of IPRP-UPLC method to prevent PS to PO conversion on column (2022)

Oligonucleotide delivery

Oligonucleotide lead identification

RNA-seq-based Nucleic Acid Therapeutics Lead Optimization (2023)

(Bio)analytics

Company

Axolabs is the leading service provider for the discovery, development and manufacture of therapeutics based on DNA or RNA.

Information

Privacy Statement

Terms & Conditions of Axolabs GmbH, Kulmbach

E-Mail: info@axolabs.com

Locations

Kulmbach, Germany

Berlin, Germany

Petaluma, CA, USA

©2024 axolabs.com

Programmierung und technische Betreuung
AS-DESIGN.Werbeagentur GmbH